Delivery Order SPE2DB22D9239-SPE2DB25FDL07
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,185.93 firm fixed-price contract is for the delivery of 4566706859 Cerdelga 84 mg capsules. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract, valued at $30,046.61, is for the delivery of Cerdelga 84 mg capsules. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $32,185.93 and has an ultimate completion date of March 7, 2025. The award is for the delivery of CERDELGA 84 MG CAPSULE 14S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty thousand forty-six dollars and sixty-one cents ($30,046.61) by the Defense Logistics Agency to provide fourteen hundred and fifty-six thousand two hundred ninety-eight (1,456,298) Cerdelga eighty-four (84) milligram capsules. The order is being issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $32,185.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 84mg capsules of the pharmaceutical product CERDELGA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,185.93 firm fixed-price delivery order is for the supply of 4565675719 CERDELGA 84 MG CAPSULE 14S, with an ultimate completion date of August 6, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue...
- The Defense Logistics Agency awarded a $30,105.64 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 14S of CERDELGA 84 MG CAPSULE under contract number 4562417305. The prime contractor DMS Pharmaceutical Group Inc. will deliver the pharmaceutical products to a location in Park Ridge, Illinois by October 19, 2023. The Defense Logistics Agency facilitates the delivery of medical supplies and pharmaceuticals to support the United States Department of Defense. This delivery...
- The Defense Logistics Agency awarded a $30,046.61 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561740661 CERDELGA 84 MG CAPSULE 14S. The prime contractor will deliver the specified pharmaceutical product to a location in Park Ridge, Illinois by August 22, 2023 in support of DLA requirements. No subcontractors or set aside designations were identified. The delivery order was issued against an unspecified DLA-wide contract vehicle and will provide Cerdelga capsules to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $32,185.93 contract is for the delivery of CERDELGA 84 MG CAPSULE 14S and has an ultimate completion date of April 4, 2024. The contract is part of a larger indefinite delivery vehicle (IDV) contract, 4600082013 under the SPE2DB program, with a ceiling value of up to $4,999,999 that enables DLA to...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. valued at thirty thousand forty-six dollars and sixty-one cents ($30,046.61) to provide fourteen thousand five hundred sixty-two thousand five hundred ninety-eight (14,562,598) capsules of Cerdelga 84 mg for use by the agency. The order was awarded on October 19, 2023 under a firm fixed price contract for delivery by November 9, 2023. Performance will occur in Park Ridge, Illinois. No set aside designation was...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL07Delivery Order
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $32,185.93 for Cerdelga 84 mg capsules (14-count packages). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The company was selected without a set-aside designation, competing on its established capabilities as a federal pharmaceutical supplier. Performance will take place at the vendor's Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's significant single-award IDC with DLA valued at $499.9 million through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare systems. The IDC covers branded and generic prescription drugs, biologics, over-the-counter medications, and specialty pharmaceuticals across multiple delivery formats. Cerdelga, a prescription medication used in the treatment of Gaucher disease, falls within this portfolio of pharmaceutical supplies that DLA distributes to Department of Defense healthcare facilities worldwide, enabling the agency to efficiently fulfill specific medical supply needs for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.2k | 8/12/25 |